Feature | April 24, 2012

Researchers Find Little Cancer Risk From CT Scans in Medicare Population

April 24, 2012 — The secondary cancer risk from multi-detector computed tomography (MDCT) scans is low among older adults, according to a study from Stanford University in the April issue of the Journal of the American College of Radiology. A high-speed imaging technique, MDCT is commonly used to diagnose a variety of diseases and conditions. 

Evidence shows that MDCT scanning offers important benefits through more accurate diagnosis and better disease management in a range of medical disorders. However, in the era of MDCT, it has been hypothesized that 1.5 percent to two percent of all cancers may be caused by CT-induced radiation.

“Our study estimates the number of excess cancers due to ionizing radiation in elderly adults. Seniors harbor most diseases that typically rely on CT scanning for diagnosis and management, and therefore receive the highest exposure to CT imaging. What our study found is that the risk of developing a secondary cancer from these CT scans may potentially be lower than previously thought,” said Aabed Meer, author of the study.

A retrospective cohort study was conducted using Medicare claims spanning eight years to assess CT use. The data were analyzed in two four-year cohorts, from 1998 to 2001 and 2002 to 2005. The number and types of CT scans each patient received over the four-year periods were analyzed to determine the percentage of patients exposed to threshold radiation of 50 to 100 mSv (defined as low) and >100 mSv (defined as high). The National Research Council’s Biological Effects of Ionizing Radiation VII models were used to estimate the number of radiation-induced cancers.

“Combining both low-risk and high-risk patient groups (50-100 and >100 mSv), as well as those who received <50 mSv, we estimate that 1,659 cases of cancer (0.03 percent of the study population) will develop in the 1998 to 2001 cohort and 2,185 (0.04 percent of the study population) in the 2002 to 2005 cohort,” said Meer.

CT scans of the head were the most common examinations in both Medicare cohorts, but abdominal imaging delivered the greatest proportion (43 percent in the first cohort and 40 percent in the second cohort) of radiation.

“Although modern CT imaging is a vital part of medical care, its utilization must include a conscious acknowledgment of radiation exposure and an awareness of the pursuant carcinogenic risk. As medical care continues its dependence on advanced technologies such as MDCT, we emphasize the importance of continuing research that encourages the exploration of lower radiation dose technologies,” said Meer.

For more information: www.jacr.org

Related Content

PFO occluder, amplatzer
Feature | Structural Heart Occluders| May 27, 2016 | Dave Fornell
May 27, 2016 — A U.S.
radial access, transradial
Feature | Radial Access| May 27, 2016 | Dave Fornell
The use of transradial artery vascular access for percutaneous coronary intervention (PCI) in the United States has s
Ambio Health telemonitoring system, LifeBridge Health Cardiovascular Institute, Baltimore, pilot study
News | Remote Monitoring| May 26, 2016
The LifeBridge Health Cardiovascular Institute, Baltimore, has launched a pilot study to evaluate the potential...
Toshiba, Infinix 4-D CT, first U.S. install, Arkansas cancer center
News | CT Angiography (CTA)| May 26, 2016
Cancer patients at the Carti Cancer Center, Conway, Ark., now have access to the latest innovation in diagnostic...
cath lab, radiation exposure, glocoma
Feature | Radiation Dose Management| May 26, 2016 | Dave Fornell
May 27, 2016 — Radiation exposure to cath lab staff and physicians has seen growing concern in recent years, as the p
Edwards, Sapien 3, SOURCE 3 Registry, EuroPCR 2016
News | Heart Valve Technology| May 24, 2016
Thirty-day data from the European post-approval study of the Edwards Sapien 3 transcatheter aortic heart valve...
News | Cath Lab| May 24, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Scientific Sessions took place May 4-7, 2016
HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA)| May 23, 2016
First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict...
TAVR outcomes, aortic valve gradient, JACC study
News | Heart Valve Technology| May 23, 2016
Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher mortality rates...
Direct Flow Medical, TAVR device, DISCOVER trial, three-year results, EuroPCR 2016
News | Heart Valve Technology| May 20, 2016
Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR...
Overlay Init